These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38531339)

  • 1. Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds.
    Pierantoni C; Cosentino L; Ricciardiello L
    Dig Dis; 2024; 42(4):319-324. PubMed ID: 38531339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic Therapy in Colorectal Cancer.
    Mody K; Baldeo C; Bekaii-Saab T
    Cancer J; 2018; 24(4):165-170. PubMed ID: 30119079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.
    Efferth T
    Curr Med Chem; 2012; 19(33):5735-44. PubMed ID: 23033949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalizing medicine for metastatic colorectal cancer: current developments.
    Marques AM; Turner A; de Mello RA
    World J Gastroenterol; 2014 Aug; 20(30):10425-31. PubMed ID: 25132758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targeting approaches and signaling pathways of colorectal cancer: An insight.
    Tiwari A; Saraf S; Verma A; Panda PK; Jain SK
    World J Gastroenterol; 2018 Oct; 24(39):4428-4435. PubMed ID: 30357011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.
    Zhou J; Ji Q; Li Q
    J Exp Clin Cancer Res; 2021 Oct; 40(1):328. PubMed ID: 34663410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in Colorectal Cancer: Antibodies.
    Chan E
    Cancer J; 2016; 22(3):179-81. PubMed ID: 27341595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.
    Ko SY; Blatch GL; Dass CR
    Cancer Metastasis Rev; 2014 Mar; 33(1):101-13. PubMed ID: 24338005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs in refractory colorectal cancer.
    Nobili S; Galletta A; Brugia M; Tassi R; Petreni P; Landini I; Mini E
    Future Med Chem; 2015 Aug; 7(12):1491-501. PubMed ID: 26293581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally designed treatment for metastatic colorectal cancer: current drug development strategies.
    Spiliopoulou P; Arkenau HT
    World J Gastroenterol; 2014 Aug; 20(30):10288-95. PubMed ID: 25132745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond Targeted Therapies in Colon Cancer Today and Tomorrow.
    Pohl M; Schmiegel W
    Dig Dis; 2016; 34(5):574-9. PubMed ID: 27332557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Angiogenics: Their Value in Colorectal Cancer Therapy.
    Seeber A; Gunsilius E; Gastl G; Pircher A
    Oncol Res Treat; 2018; 41(4):188-193. PubMed ID: 29562227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer.
    Salva de Torres C; Baraibar I; Saoudi González N; Ros J; Salva F; Rodríguez-Castells M; Alcaraz A; García A; Tabernero J; Élez E
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted therapies in digestive oncology].
    Amram ML; Benamran DA; Roth AD
    Rev Med Suisse; 2011 May; 7(296):1131-2, 1134-6. PubMed ID: 21721202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
    Piawah S; Venook AP
    Cancer; 2019 Dec; 125(23):4139-4147. PubMed ID: 31433498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Triage Trials in Colorectal Cancer.
    O'Hara MH; Hamilton SR; O'Dwyer PJ
    Cancer J; 2016; 22(3):218-22. PubMed ID: 27341602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy.
    Sun W
    J Hematol Oncol; 2012 Oct; 5():63. PubMed ID: 23057939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the EGFR signalling pathway in metastatic colorectal cancer.
    Napolitano S; Martini G; Ciardiello D; Del Tufo S; Martinelli E; Troiani T; Ciardiello F
    Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):664-676. PubMed ID: 38697174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.
    Hanna DL; Lenz HJ
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1091-108. PubMed ID: 27031164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.